Trademark: 90492343
Word
SOPHIE
Status
Pending
Status Code
733
Status Date
Tuesday, August 27, 2024
Serial Number
90492343
Mark Type
4
Filing Date
Wednesday, January 27, 2021
Published for Opposition
Tuesday, September 21, 2021

Trademark Owner History
Teva Pharmaceuticals USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

Trademark Events
Jan 30, 2021
New Application Entered
Apr 29, 2021
New Application Office Supplied Data Entered
Aug 13, 2021
Assigned To Examiner
Aug 16, 2021
Approved For Pub - Principal Register
Sep 1, 2021
Notification Of Notice Of Publication E-Mailed
Sep 21, 2021
Published For Opposition
Nov 10, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 10, 2021
Teas Change Of Correspondence Received
Sep 21, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 10, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 10, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 16, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 21, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 23, 2022
Teas Petition To Revive Received
May 16, 2022
Notice Of Allowance Cancelled
Jun 20, 2022
Abandonment - No Use Statement Filed
Jun 23, 2022
Notice Of Revival - E-Mailed
Jun 23, 2022
Petition To Revive-Granted
Jul 29, 2022
Case Assigned To Intent To Use Paralegal
Jul 29, 2022
New Noa To Issue
Sep 6, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 22, 2023
Sou Extension 1 Filed
Feb 22, 2023
Sou Extension 1 Granted
Feb 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 1, 2023
Sou Teas Extension Received
Feb 22, 2023
Sou Teas Extension Received
Sep 1, 2023
Sou Extension 2 Filed
Sep 1, 2023
Sou Extension 2 Granted
Sep 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2024
Sou Teas Extension Received
Mar 2, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2024
Sou Extension 3 Filed
Mar 1, 2024
Sou Extension 3 Granted
Aug 27, 2024
Sou Teas Extension Received
Aug 27, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 27, 2024
Sou Extension 4 Filed
Aug 27, 2024
Sou Extension 4 Granted

Trademark Alertz updated from USPTO on 2030-01-24